Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
PaperCitations, authors & open-access status
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 282 citations, 2022 year and gold oa status.
282
Citations
2022
Year
gold
OA Status